BARI, ELIA
 Distribuzione geografica
Continente #
NA - Nord America 1340
EU - Europa 850
AS - Asia 458
AF - Africa 4
OC - Oceania 1
SA - Sud America 1
Totale 2654
Nazione #
US - Stati Uniti d'America 1305
IE - Irlanda 580
CN - Cina 447
IT - Italia 134
DE - Germania 41
CA - Canada 35
SE - Svezia 25
BE - Belgio 23
FR - Francia 18
FI - Finlandia 15
GB - Regno Unito 7
BD - Bangladesh 4
MU - Mauritius 4
NL - Olanda 4
IN - India 3
RU - Federazione Russa 2
AU - Australia 1
BR - Brasile 1
CH - Svizzera 1
HK - Hong Kong 1
IR - Iran 1
MY - Malesia 1
TH - Thailandia 1
Totale 2654
Città #
Dublin 574
Chandler 541
Nanjing 114
Princeton 90
Lawrence 89
Medford 88
Beijing 67
Wilmington 64
Ann Arbor 55
Pavia 44
Nanchang 42
Dearborn 36
Shenyang 36
Hebei 34
Toronto 34
Changsha 32
Hangzhou 30
Jiaxing 30
Brussels 21
Jacksonville 21
Piemonte 16
Redwood City 14
Tianjin 14
Helsinki 12
Norwalk 10
Fairfield 8
Kunming 8
Woodbridge 8
Xian 7
Ashburn 6
Des Moines 6
San Mateo 6
Travaco Siccomario 6
Berlin 5
Cambridge 5
Hefei 5
Houston 5
Ningbo 5
Rome 5
Boardman 4
Dhaka 4
Jinan 4
Chengdu 3
Dallas 3
Guangzhou 3
Orange 3
Padova 3
Zhengzhou 3
Borås 2
Böblingen 2
Cedar Knolls 2
Como 2
Cornigliano 2
Gent 2
Guidonia 2
Leawood 2
Legnano 2
Mantova 2
Munich 2
Phoenix 2
Redmond 2
Rockville 2
Shanghai 2
Taizhou 2
Terracina 2
Yonkers 2
Abbiategrasso 1
Andover 1
Ardabil 1
Ban Nong Sala 1
Buccinasco 1
Chiasso 1
Chicago 1
College Park 1
Fuzhou 1
Huizen 1
Markham 1
Melbourne 1
Melegnano 1
Milan 1
Monmouth Junction 1
Montichiari 1
Reggio Calabria 1
Reston 1
Rotterdam 1
Torino 1
Wuhan 1
Zheleznovodsk 1
Totale 2281
Nome #
Lyosecretome for use in the treatment or prevention of skin aging by inhibiting elastase and tyrosinase activity 68
Lyosecretome for use in the treatment of autoimmune diseases 65
Lyosecretome for use in the treatment of degenerative osteoarticular diseases and/or degenerative intervertebral disc disease. 60
Silk sericin and platelet lysate for intervertebral disc cell culture 57
Processo per isolare e liofilizzare vescicole extracellulari 54
Freeze-dried MSC-secretome contains active alpha-1-antitrypsin for treatment of deficiency pulmonary diseases 51
Silk fibroin nanoparticles for Celecoxib and Curcumin delivery: ROS-scavenging and anti-inflammatory activities in an in vitro model of osteoarthrit 46
Equine freeze-dried secretome for joint regeneration in veterinary medicine: production process and in vitro efficacy 46
Lyosecretome for use in the treatment of alpha-1-antitrypsin deficiency associated diseases 45
Freeze-dried MSC-secretome for use in the treatment of alpha-1-antitrypsin deficiency pulmonary diseases 45
Combining Inulin and Cyclodextrin for colon drug release 44
Isolation and characterization of B. mori silk sericin for topical applications 42
Cross-linked silk sericin microparticles as bioactive delivery system: formulation and in vitro cytotoxicity 42
Crocetin as New Cross-Linker for Bioactive Sericin Nanoparticles 42
Efficacy of a freeze-dried product based on MSC-secretome (Lyosecretome) in a wound healing murine model. 41
Silk fibroin nanoparticles for Celecoxib and Curcumin delivery: in vitro efficacy in an osteoarthritis model 41
Freeze-dried pharmaceutical formulations containing mesenchymal exosomes for acellular MSC immunomodulant therapy 41
Biohybrid bovine bone matrix for controlled release of mesenchymal stem/stromal cell lyosecretome: A device for bone regeneration 41
3D Bioprinted Scaffolds Containing Mesenchymal Stem/Stromal Lyosecretome: Next Generation Controlled Release Device for Bone Regenerative Medicine 41
Sericin microparticles as bioactive carriers for local drug delivery: in vitro cytocompatibility profile 40
Controlled release of celecoxib from inulin based micelles 39
Association of silk sericin and platelet lysate: Premises for the formulation of wound healing active medications 38
Equine Mesenchymal Stem/Stromal Cells Freeze-Dried Secretome (Lyosecretome) for the Treatment of Musculoskeletal Diseases: Production Process Validation and Batch Release Test for Clinical Use 38
Human engineered cartilage and decellularized matrix as an alternative to animal osteoarthritis model 36
Mesenchymal Extracellular Vesicles as Alpha-1-antitrypsin physiological delivery systems for lung regeneration 36
Synthesis of differently bioconjugated novel c-RGD antagonist 36
In vitro cytotoxicity and potency of freeze-dried MSC-secretome (Lyosecretome). 35
MSC extracellular vesicles for treatment of alpha-1-antitrypsin deficiency pulmonary diseases 35
Canine lyo-secretome for osteoarticular regeneration in veterinary medicine: pilot-production and in vitro efficacy 35
Adipose Mesenchymal Extracellular Vesicles as Alpha-1-Antitrypsin Physiological Delivery Systems for Lung Regeneration 35
Characterization and antioxidant activity of essential oil of four sympatric orchid species 35
Production, characterization, and in vitro efficacy of canine and equine lyo-secretome injectable formulation in regenerative medicine 35
Freeze-dried MSC-secretome (Lyosecretome) for regenerative medicine applications: pharmaceutical development. 34
Freeze-dried and GMP-compliant pharmaceuticals containing mesenchymal exosomes for acellular MSC immunomodulant therapy 34
3D Bioprinted Scaffolds for controlled release of Mesenchymal Stem/Stromal Lyo-secretome in Bone Regeneration 34
Canine mesenchymal Lyosecretome production and clinical use in osteoarthritic dogs. 34
Pharmaceutical development of freeze-dried extracellular vesicles. 33
Mesenchymal stem/stromal cell Lyosecretome for next generation cell-free regenerative nanomedicine: in vitro cytotoxicity and potency 32
In vitro efficacy of platelet lysate in association with silk sericin for intervertebral disk regeneration 32
From mesenchymal stem/stromal cells to cell products: pharmaceutical development of secretome as new biological medicinal product 32
Auricchio F, Bari E, Conti M, Perteghella S, Scocozza F, Sorlini M, Torre ML. Scaffold per la rigenerazione tissutale, in particolare per la rigenerazione ossea, e relativo metodo di fabbricazione. 32
Osteoinductive and osteoconductive properties of 3D Printed scaffolds containing Mesenchymal Stem/Stromal Lyosecretome 31
Freeze-dried and GMP-compliant pharmaceuticals containing exosomes for acellular mesenchymal stromal cell immunomodulant therapy 30
Efficacy of sponge-like dressing containing MSC lyo-secretome in a wound healing murine model 30
Production, characterization, and in vitro efficacy of a canine lyo-secretome injectable formulation for osteoarticular regeneration 30
From Bench to Bedside: The Long Way Towards GMP Scale-up, Preclinical and Clinical Trials for Silk-based Drug Delivery Systems 30
Scaffold for tissue regeneration, particularly for bone regeneration, and manufacturing method thereof. 30
Stem cell-extracellular vesicles loading silk/curcumin nanoparticles for drug delivery 29
Canine mesenchymal stem cell lyo-secretome: in vitro potency evaluation and in vivo preliminary application in dogs with naturally occurring osteoarthritis 29
Silk Fibroin Nanoparticle Functionalized with Arg-Gly-Asp cyclopentapeptide: Tumor specific Active Targeting 29
Freeze-dried secretome from mesenchymal stromal cells: a phase I clinical trial for equine and canine musculoskeletal diseases 29
From mesenchymal stem/stromal cells to cell products: pharmaceutical evelompment of secretome as new biological medicinal product 28
Pilot production of mesenchymal stem/stromal freeze-dried secretome for cell-free regenerative nanomedicine: a validated GMP-compliant process. 28
Nanoparticles for use in the redirection against the tumour of a non-tumour-specific immune response, based on a pre-existing immunity 28
Silk Fibroin Nanoparticle Functionalization with Arg-Gly-Asp cyclopentapeptide Promotes Active Targeting for Tumor Site-Specific Delivery 28
Silk Fibroin Nanoparticle to Redirected Immunity Against Cancer 28
Mesenchymal stem/stromal cell Lyosecretome for next generation cell-free regenerative nanomedicine: efficacy in a murine model of wound healing 27
Sponge-like formulations containing MSC lyo-secretome: efficacy in a wound healing murine model 27
Alternative culture media and cold-drying for obtaining high biological value Arthrospira platensis (Cyanobacteria) 27
Technological Development of Freeze-dried Mesenchymal Stem Cell Secretome Formulations 27
Osteoinductive and osteoconductive properties of Biohybrid Bovine Bone Matrix containing Mesenchymal Stem/Stromal Cell Lyosecretome 27
Chromatographic profiling of silk sericin for biomedical and cosmetic use by complementary hydrophylic, reversed phase and size exclusion chromatographic methods 26
Silk sericin: from textile waste material to dermatological and cosmetic applications 26
Osteoinductive and osteoconductive properties of titanium cages containing Mesenchymal Stem/Stromal Lyosecretome. 26
Pharmaceutical development of mesenchymal extracellular vescicle formulations 23
Mesenchymal Stromal Cell Secretome for Post-COVID-19 Pulmonary Fibrosis: A New Therapy to Treat the Long-Term Lung Sequelae? 23
Preparation and characterization of polyphenols-loaded silk sericin self-assembling nanosystems 22
Mesenchymal stem/stromal cell Lyosecretome for next generation cell-free regenerative nanomedicine 21
Mesenchymal stem/stromal cell secretome for lung regeneration: The long way through “pharmaceuticalization” for the best formulation. 21
Polyphenols-Loaded Sericin Self-Assembling Nanoparticles: A Slow-Release for Regeneration by Tissue-Resident Mesenchymal Stem/Stromal Cells 21
Silk 21
Silk fibroin nanoparticles to redirect immunity against different cancers: proof of concept in a murine model. 21
Silk-sericin Nano-drug Delivery Systems 20
Scaffold for tissue regeneration, particularly for bone regeneration, and manufacturing method thereof. 20
Scaffold per la rigenerazione ossea e relativo metodo di fabbricazione 20
Silk-fibroin Micro-drug Delivery Systems 19
GMP validation of production process for freeze-dried secretome from bone marrow mesenchymal stem/stromal cells 19
Veterinary Regenerative Medicine for Musculoskeletal Disorders: Can Mesenchymal Stem/Stromal Cells and Their Secretome Be the New Frontier? 19
Extracellular vesicles for lung regeneration in alpha-1-antitrypsin deficiency 18
From mesenchymal stem/stromal cells to cell products: pharmaceutical development of secretome as new biological medicinal product 16
GMP validation of production process for freeze-dried secretome from bone marrow mesenchymal stem/stromal cells 15
Silk-based Drug Delivery Systems 15
A new human platelet lysate for mesenchymal stem cell production compliant with Good Manufacturing Practice conditions preserve chemical characteristics and biological activity of lyo-secretome isolated by ultrafiltration 15
Silk-sericin Micro-drug Delivery Systems 14
Growth Factors Delivery System for Skin Regeneration: An Advanced Wound Dressing 13
Silk-fibroin Nano-drug Delivery Systems 12
GMP-compliant sponge like dressing containing MSC lyo-secretome: proteomic network of healing in a murine wound model 12
Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use 11
cRGD-Functionalized Silk Fibroin Nanoparticles: A Strategy for Cancer Treatment with a Potent Unselective Naphthalene Diimide Derivative 9
GMP-compliant sponge-like dressing containing MSC lyo-secretome: proteomic network of healing in a murine wound model 9
Totale 2781
Categoria #
all - tutte 6778
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6778


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201814 0000 00 00 01202
2018/201993 201816 70 114 214019
2019/2020557 1392351027 79 2432 2027234
2020/2021152 23511 219 1331 13141515
2021/2022492 135110 621 631 24598236
2022/20231435 1911132999 95143 665 694000
Totale 2781